Keywordsbiofilm; inactivation; S. aureus; MRSA; VRSA; octenidine hydrochloride; antimicrobial activity; biofilms; quorum-sensing inhibition; phytochemicals; resistance; synergism; bacteria; biofilm; biomaterial; Gram-negative; infection; quorum sensing; Pseudomonas aeruginosa; cystic fibrosis; clonal diversification; phenotypic variation; mucoid phenotype; Acinetobacter baumannii; biofilm; chelator; deferasirox; deferiprone; deferoxamine; dipyridyl; iron; transferrin; biofilm; healthcare-associated infections (HAI); antibiotic resistance; scanning electron microscopy (SEM); Klebsiella pneumonia; biofilm; antibiotic resistance; Staphylococcus aureus biofilm; VBNC; daptomycin; antimicrobial; bacteria; biofilm; biomaterial; infection; peptide; self-assembly; candidiasis; Candida albicans; chitosan; biofilm; antibiofilm; biofilm; eye; ocular infections, postoperative ocular infections; device-related ocular infections
